TearLab Stock Price, News & Analysis (OTCMKTS:TEAR)

$0.41 -0.01 (-2.38 %)
(As of 01/21/2018 04:00 PM ET)
Previous Close$0.41
Today's Range$0.38 - $0.42
52-Week Range$0.31 - $7.50
Volume141,831 shs
Average Volume58,341 shs
Market Capitalization$3.18 million
P/E RatioN/A
Dividend YieldN/A
Beta2.72

About TearLab (OTCMKTS:TEAR)

TearLab logoTearLab Corporation is an in-vitro diagnostic company. The Company has commercialized a tear testing platform, the TearLab Osmolarity System, which enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company, through its subsidiary TearLab Research, Inc., develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites, genes and proteins) at the point-of-care. Its product, the TearLab Osmolarity System, enables the measurement of tear osmolarity in the doctor's office. The TearLab Osmolarity System consists of approximately three components: the TearLab disposable, the TearLab Pen, and the TearLab Reader. The TearLab disposable is a single-use microfluidic microchip. The TearLab Pen is a hand-held device that interfaces with the TearLab disposable. The TearLab Reader is a small desktop unit that allows for the docking of the TearLab Pen.

Receive TEAR News and Ratings via Email

Sign-up to receive the latest news and ratings for TEAR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Glasses, Spectacles & Contact lenses
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:TEAR
CUSIPN/A
Phone858-455-6006

Debt

Debt-to-Equity Ratio-1.62%
Current Ratio2.19%
Quick Ratio1.75%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$28.01 million
Price / Sales0.11
Cash FlowN/A
Price / CashN/A
Book Value($1.07) per share
Price / Book-0.38

Profitability

Trailing EPS($2.98)
Net Income$-19,920,000.00
Net Margins-60.22%
Return on EquityN/A
Return on Assets-75.54%

Miscellaneous

Employees75
Outstanding Shares7,760,000

TearLab (OTCMKTS:TEAR) Frequently Asked Questions

What is TearLab's stock symbol?

TearLab trades on the OTCMKTS under the ticker symbol "TEAR."

When did TearLab's stock split? How did TearLab's stock split work?

Shares of TearLab reverse split before market open on Friday, February 24th 2017. The 1-10 reverse split was announced on Friday, February 24th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, February 23rd 2017. An investor that had 100 shares of TearLab stock prior to the reverse split would have 10 shares after the split.

How were TearLab's earnings last quarter?

TearLab Corp (OTCMKTS:TEAR) announced its quarterly earnings data on Monday, November, 13th. The medical research company reported ($0.67) earnings per share for the quarter, topping analysts' consensus estimates of ($0.73) by $0.06. The medical research company earned $6.52 million during the quarter, compared to analyst estimates of $6.80 million. View TearLab's Earnings History.

When will TearLab make its next earnings announcement?

TearLab is scheduled to release their next quarterly earnings announcement on Thursday, March, 8th 2018. View Earnings Estimates for TearLab.

Where is TearLab's stock going? Where will TearLab's stock price be in 2018?

4 brokerages have issued twelve-month target prices for TearLab's stock. Their predictions range from $4.00 to $9.00. On average, they expect TearLab's share price to reach $5.75 in the next twelve months. View Analyst Ratings for TearLab.

Who are some of TearLab's key competitors?

Who are TearLab's key executives?

TearLab's management team includes the folowing people:

  • Elias Vamvakas, Chairman of the Board (Age 58)
  • Joseph S. Jensen, President, Chief Executive Officer, Chief Operating Officer, Director (Age 45)
  • Wes Brazell, Chief Financial Officer (Age 51)
  • Anthony E. Altig, Independent Director (Age 61)
  • Thomas N. Davidson Jr., Independent Director (Age 57)
  • Adrienne L. Graves Ph.D., Independent Director (Age 63)
  • Paul M. Karpecki, Independent Director (Age 49)
  • Richard L. Lindstrom M.D., Independent Director (Age 69)

How do I buy TearLab stock?

Shares of TearLab can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is TearLab's stock price today?

One share of TearLab stock can currently be purchased for approximately $0.41.

How big of a company is TearLab?

TearLab has a market capitalization of $3.18 million and generates $28.01 million in revenue each year. The medical research company earns $-19,920,000.00 in net income (profit) each year or ($2.98) on an earnings per share basis. TearLab employs 75 workers across the globe.

How can I contact TearLab?

TearLab's mailing address is 9980 Huennekens Street Suite 100, San Diego CA, 92121. The medical research company can be reached via phone at 858-455-6006 or via email at [email protected]


MarketBeat Community Rating for TearLab (TEAR)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  233 (Vote Outperform)
Underperform Votes:  119 (Vote Underperform)
Total Votes:  352
MarketBeat's community ratings are surveys of what our community members think about TearLab and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

TearLab (OTCMKTS:TEAR) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.002.80
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $5.75$5.75$5.75$5.75
Price Target Upside: 164.98% upside164.98% upside164.98% upside121.15% upside

TearLab (OTCMKTS:TEAR) Consensus Price Target History

Price Target History for TearLab (OTCMKTS:TEAR)

TearLab (OTCMKTS:TEAR) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
8/15/2017HC WainwrightReiterated RatingBuy$4.00View Rating Details
5/16/2017Rodman & RenshawLower Price TargetBuy -> Buy$12.00 -> $4.00View Rating Details
3/11/2017Craig HallumSet Price TargetBuy$6.00View Rating Details
3/11/2017Feltl & Co.DowngradeStrong-Buy -> Buy$9.00View Rating Details
8/4/2016Roth CapitalDowngradeBuy -> NeutralView Rating Details
3/9/2016Canaccord GenuityReiterated RatingBuyView Rating Details
(Data available from 1/21/2016 forward)

Earnings

TearLab (OTCMKTS:TEAR) Earnings History and Estimates Chart

Earnings by Quarter for TearLab (OTCMKTS:TEAR)

TearLab (OTCMKTS TEAR) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/8/2018        
11/13/2017Q3 2017($0.73)($0.67)$6.80 million$6.52 millionViewN/AView Earnings Details
8/14/2017Q2 2017($0.75)($0.68)$6.86 million$7.00 millionViewN/AView Earnings Details
5/15/2017Q1 2017($0.75)($0.82)$7.02 million$6.70 millionViewN/AView Earnings Details
3/9/2017Q4 2016($0.90)($0.81)$7.71 million$7.12 millionViewListenView Earnings Details
11/7/2016Q316($0.08)($0.07)$7.13 million$20.90 millionViewListenView Earnings Details
8/3/2016Q2($0.08)($0.08)$6.95 million$6.90 millionViewN/AView Earnings Details
5/4/2016Q1($0.23)($0.21)$6.53 million$6.80 millionViewN/AView Earnings Details
3/8/2016Q4($0.25)($0.26)$6.83 million$6.80 millionViewN/AView Earnings Details
11/5/2015Q315($0.24)($0.24)$6.40 million$6.60 millionViewN/AView Earnings Details
8/6/2015Q215($0.25)($0.24)$5.72 million$6.30 millionViewN/AView Earnings Details
5/7/2015Q115($0.21)($0.25)$5.40 million$5.40 millionViewN/AView Earnings Details
3/12/2015Q414($0.17)($0.21)$5.50 million$5.30 millionViewN/AView Earnings Details
11/5/2014Q214($0.17)($0.17)$5.50 million$5.20 millionViewN/AView Earnings Details
8/7/2014Q114($0.16)($0.17)$5.12 million$9.20 millionViewN/AView Earnings Details
5/8/2014Q1($0.14)($0.17)$4.76 million$4.21 millionViewN/AView Earnings Details
3/13/2014Q413($0.13)($0.13)$4.49 million$4.40 millionViewN/AView Earnings Details
11/12/2013Q3($0.14)($0.13)$3.80 million$4.20 millionViewListenView Earnings Details
8/13/2013Q2 2013($1.30)($1.50)ViewN/AView Earnings Details
5/13/2013Q1 2013($0.12)($0.30)$2.18 million$2.47 millionViewN/AView Earnings Details
3/20/2013Q4 2012($1.10)($1.20)ViewN/AView Earnings Details
11/13/2012Q312($0.11)($0.10)$1.20 millionViewN/AView Earnings Details
8/8/2012Q2 2012($1.00)($1.12)ViewN/AView Earnings Details
5/14/2012Q1 2012($1.10)($1.21)ViewN/AView Earnings Details
3/22/2012Q4 2011($1.00)($1.36)ViewN/AView Earnings Details
11/10/2011Q3 2011$0.50ViewN/AView Earnings Details
8/10/2011Q2 2011($1.87)ViewN/AView Earnings Details
5/11/2011Q1 2011($1.13)ViewN/AView Earnings Details
3/28/2011Q4 2010($0.61)ViewN/AView Earnings Details
11/11/2010Q3 2010($1.46)ViewN/AView Earnings Details
8/12/2010Q2 2010($1.17)ViewN/AView Earnings Details
5/11/2010Q1 2010($1.66)ViewN/AView Earnings Details
3/25/2010Q4 2009($1.62)ViewN/AView Earnings Details
11/12/2009Q3 2009($0.66)ViewN/AView Earnings Details
8/12/2009Q2 2009($1.03)ViewN/AView Earnings Details
5/14/2009Q1 2009($1.02)ViewN/AView Earnings Details
3/26/2009Q4 2008($6.08)ViewN/AView Earnings Details
11/10/2008Q3 2008($9.75)ViewN/AView Earnings Details
8/6/2008Q2 2008($6.25)ViewN/AView Earnings Details
5/7/2008Q1 2008($12.75)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

TearLab (OTCMKTS:TEAR) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for TearLab (OTCMKTS:TEAR)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

TearLab (OTCMKTS TEAR) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 12.00%
Institutional Ownership Percentage: 9.00%
Insider Trades by Quarter for TearLab (OTCMKTS:TEAR)
Institutional Ownership by Quarter for TearLab (OTCMKTS:TEAR)

TearLab (OTCMKTS TEAR) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/30/2017Awm Investment Company, Inc.Major ShareholderSell327,674$3.20$1,048,556.80View SEC Filing  
5/31/2016Brock WrightDirectorBuy59,686$0.78$46,555.08808,378View SEC Filing  
5/26/2016Brock WrightDirectorBuy130,314$0.76$99,038.64719,732View SEC Filing  
12/4/2014Elias VamvakasCEOBuy50,000$2.24$112,000.00View SEC Filing  
11/18/2014Elias VamvakasCEOBuy31,187$2.55$79,526.85View SEC Filing  
11/17/2014Elias VamvakasCEOBuy18,813$2.55$47,973.15View SEC Filing  
11/11/2014Elias VamvakasCEOBuy150,000$2.49$373,500.00View SEC Filing  
11/10/2014Elias VamvakasCEOBuy16,276$2.50$40,690.00View SEC Filing  
11/10/2014Joseph JensenCOOBuy43,375$2.31$100,196.25View SEC Filing  
8/20/2014Brock WrightDirectorBuy23,000$3.82$87,860.00View SEC Filing  
8/19/2014Brock WrightDirectorBuy11,354$3.83$43,485.82View SEC Filing  
8/12/2014Elias VamvakasCEOBuy70,000$3.43$240,100.00View SEC Filing  
6/30/2014Richard LindstromDirectorSell5,000$4.61$23,050.00View SEC Filing  
5/13/2014Elias VamvakasCEOBuy30,000$3.99$119,700.00201,404View SEC Filing  
5/13/2014Joseph JensenCOOBuy48,693$4.11$200,128.2348,693View SEC Filing  
4/1/2014Paul KarpeckiDirectorSell5,000$6.83$34,150.003,500View SEC Filing  
1/2/2014Paul KarpeckiDirectorSell5,000$9.47$47,350.003,500View SEC Filing  
12/31/2013Richard LindstromDirectorSell5,000$9.26$46,300.0086,238View SEC Filing  
11/15/2013Richard LindstromDirectorSell5,000$8.95$44,750.0086,238View SEC Filing  
10/11/2013Paul KarpeckiDirectorSell5,000$10.96$54,800.003,500View SEC Filing  
9/3/2013William DumencuCFOSell7,000$13.22$92,540.00View SEC Filing  
8/1/2013William DumencuCFOSell7,000$14.39$100,730.00View SEC Filing  
7/1/2013Paul KarpeckiDirectorSell5,000$10.62$53,100.00View SEC Filing  
7/1/2013William DumencuCFOSell7,000$10.61$74,270.00View SEC Filing  
6/3/2013William DumencuCFOSell7,000$11.35$79,450.00View SEC Filing  
4/2/2013Tom Jr. DavidsonDirectorBuy1,500$6.63$9,945.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

TearLab (OTCMKTS TEAR) News Headlines

Source:
DateHeadline
Contrasting TearLab (TEAR) & Cooper Companies (COO)Contrasting TearLab (TEAR) & Cooper Companies (COO)
www.americanbankingnews.com - December 13 at 5:12 AM
Financial Contrast: LightPath Technologies (LPTH) vs. TearLab (TEAR)Financial Contrast: LightPath Technologies (LPTH) vs. TearLab (TEAR)
www.americanbankingnews.com - December 11 at 3:10 AM
TearLab (TEAR) versus LightPath Technologies (LPTH) Financial ComparisonTearLab (TEAR) versus LightPath Technologies (LPTH) Financial Comparison
www.americanbankingnews.com - December 10 at 9:08 PM
LightPath Technologies (LPTH) and TearLab (TEAR) Critical SurveyLightPath Technologies (LPTH) and TearLab (TEAR) Critical Survey
www.americanbankingnews.com - December 10 at 3:26 AM
TearLab (TEAR) Prices 6.82M Share Registered Direct Offering at $0.44/ShTearLab (TEAR) Prices 6.82M Share Registered Direct Offering at $0.44/Sh
www.streetinsider.com - December 7 at 11:45 AM
Financial Survey: TearLab (TEAR) versus LightPath Technologies (LPTH)Financial Survey: TearLab (TEAR) versus LightPath Technologies (LPTH)
www.americanbankingnews.com - December 4 at 8:44 AM
TearLab Launches Registered Direct Offering - GlobeNewswire (press release)TearLab Launches Registered Direct Offering - GlobeNewswire (press release)
globenewswire.com - December 2 at 8:08 AM
Reviewing Cooper Companies (COO) & TearLab (TEAR)Reviewing Cooper Companies (COO) & TearLab (TEAR)
www.americanbankingnews.com - December 1 at 3:54 PM
Critical Analysis: LightPath Technologies (LPTH) versus TearLab (TEAR)Critical Analysis: LightPath Technologies (LPTH) versus TearLab (TEAR)
www.americanbankingnews.com - November 30 at 5:28 PM
TearLab Launches Registered Direct OfferingTearLab Launches Registered Direct Offering
finance.yahoo.com - November 30 at 11:59 AM
TearLab Corp. :TEAR-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017TearLab Corp. :TEAR-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017
finance.yahoo.com - November 29 at 11:18 AM
Critical Review: TearLab (TEAR) versus Cooper Companies (COO)Critical Review: TearLab (TEAR) versus Cooper Companies (COO)
www.americanbankingnews.com - November 27 at 7:08 PM
Analyzing TearLab (TEAR) & Cooper Companies (COO)Analyzing TearLab (TEAR) & Cooper Companies (COO)
www.americanbankingnews.com - November 27 at 5:28 AM
Contrasting TearLab Corporation (TEAR) & Cooper Companies, Inc. (The) (COO)Contrasting TearLab Corporation (TEAR) & Cooper Companies, Inc. (The) (COO)
www.americanbankingnews.com - November 17 at 9:23 AM
Cooper Companies, Inc. (The) (COO) vs. TearLab Corporation (TEAR) Head to Head AnalysisCooper Companies, Inc. (The) (COO) vs. TearLab Corporation (TEAR) Head to Head Analysis
www.americanbankingnews.com - November 17 at 8:36 AM
Comparing TearLab Corporation (TEAR) and LightPath Technologies (LPTH)Comparing TearLab Corporation (TEAR) and LightPath Technologies (LPTH)
www.americanbankingnews.com - November 16 at 9:54 PM
Analyzing TearLab Corporation (TEAR) and Cooper Companies, Inc. (The) (COO)Analyzing TearLab Corporation (TEAR) and Cooper Companies, Inc. (The) (COO)
www.americanbankingnews.com - November 16 at 3:50 PM

SEC Filings

TearLab (OTCMKTS:TEAR) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

TearLab (OTCMKTS:TEAR) Income Statement, Balance Sheet and Cash Flow Statement

Chart

TearLab (OTCMKTS TEAR) Stock Chart for Sunday, January, 21, 2018

Loading chart…

This page was last updated on 1/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.